OncoMed Pharmaceuticals

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment by creating novel medicines that address the fundamental biologic pathways critical to tumor initiation, growth, metastases and recurrence. We are leveraging our understanding of cancer stem cell pathways and immuno-oncology targets to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer. OncoMed currently has seven internally discovered drug candidates in clinical development, as well as several active research programs undergoing preclinical evaluation. To support the advancement of our clinical-stage candidates and our continued discovery efforts, OncoMed has formed strategic alliances with Celgene Corporation,...

Oncology,drug development,biotechnology,biopharmaceuticals,immuno-oncology,cancer stem cells,redwood city,innovation,science,lung cancer,and pancreatic cancer

Oncomed pharmaceuticals operates in the Biotechnology research industry.

Oncomed pharmaceuticals's revenue is 11m - 100m

Oncomed pharmaceuticals has 11 - 50 employees.